Opportunity Information: Apply for PAR 11 145

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "International Research in Infectious Diseases, including AIDS (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855 Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research.
  • This funding opportunity was created on Mar 11, 2011 and posted on Mar 11, 2011.
  • Applicants must submit their applications by Aug 23, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Other Eligible Applicants include the following Resource constrained Non domestic (non U.S.) Entities (Foreign Organizations) ONLY Foreign (non U.S.) components of U.S. Organizations are not allowed.
Apply for PAR 11 145

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The funding opportunity titled "International Research in Infectious Diseases, including AIDS (R01)" (Funding Opportunity Number PAR-11-145) is a limited-competition grant program from the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID). It supports investigator-initiated research projects using the NIH Research Project Grant (R01) mechanism, with a focus on infectious diseases, including HIV/AIDS, that are important to the applicant country. In practical terms, the program is designed to strengthen and enable high-quality infectious disease research led by institutions based in eligible foreign, resource-constrained settings, where the research questions are closely tied to local public health priorities and disease burdens.

The opportunity falls under NIH discretionary funding and is categorized in the health funding activity area. It is associated with CFDA numbers 93.855 (Allergy, Immunology and Transplantation Research) and 93.856 (Microbiology and Infectious Diseases Research), which signals that NIAID is looking for research aligned with its broader mission in immunology, microbial pathogenesis, infectious disease biology, prevention, and related translational or clinical work. While the summary description is brief, the title and NIAID scope imply that proposed projects could span a wide range of infectious disease topics, potentially including basic, clinical, epidemiological, and implementation-oriented research, as long as the work is scientifically rigorous and clearly relevant to the infectious disease challenges faced by the country where the applicant institution is located.

Eligibility is tightly defined. Applications are restricted to non-U.S. (foreign) organizations located in eligible foreign countries, with an emphasis on resource-constrained entities. Importantly, foreign components of U.S. organizations are explicitly not allowed, meaning a U.S. institution cannot apply through its overseas branch or affiliate to access this particular FOA. This structure underscores the intent of the program: to fund and empower independent, locally based research institutions rather than extensions of U.S.-based applicants. There is no cost sharing or matching requirement, so applicants are not required to contribute a specified portion of project costs from non-federal sources as a condition of award.

Key timeline details show that the FOA was posted and created on March 11, 2011, with an original and final application closing date of August 23, 2013. The announcement was archived on September 23, 2013, meaning it is no longer active for new submissions, but it remains relevant as a reference point for the type of international infectious disease research NIAID has sought to stimulate through targeted limited competitions.

For applicants or readers seeking the full official announcement, NIH provided an additional information link to the archived FOA page (http://grants.nih.gov/grants/guide/pa-files/PAR-11-145.html). NIH also listed support contacts through the NIH Office of Extramural Research (OER) webmaster for technical access or linking issues (FBOWebmaster@OD.NIH.GOV), reflecting standard NIH practice for assisting users who cannot retrieve the full posting online.

Frequently Asked Questions (FAQs)

What is the official title of this funding opportunity?

The opportunity is titled "International Research in Infectious Diseases, including AIDS (R01)."

What is the Funding Opportunity Number (FOA number)?

The Funding Opportunity Number is PAR-11-145.

Which federal agency and NIH institute sponsor this opportunity?

This is a National Institutes of Health (NIH) funding opportunity sponsored by the National Institute of Allergy and Infectious Diseases (NIAID).

What type of grant mechanism does this program use?

The program uses the NIH Research Project Grant (R01) mechanism and supports investigator-initiated research projects.

Is this a limited-competition opportunity?

Yes. It is described as a limited-competition grant program.

What is the main research focus of the opportunity?

The focus is on infectious diseases, including HIV/AIDS, with an emphasis on topics that are important to the applicant country and aligned with local public health priorities and disease burdens.

What kind of research areas might be supported under this announcement?

Based on the title and NIAID scope described, projects may span infectious disease research such as basic, clinical, epidemiological, translational, prevention-related, and implementation-oriented studies, as long as they are scientifically rigorous and clearly relevant to the infectious disease challenges in the country where the applicant institution is located.

Who is eligible to apply?

Applications are restricted to non-U.S. (foreign) organizations located in eligible foreign countries, with an emphasis on institutions in resource-constrained settings.

Can a U.S. organization apply through a foreign branch or affiliate?

No. Foreign components of U.S. organizations are explicitly not allowed under this opportunity, meaning a U.S. institution cannot apply through an overseas branch or affiliate for this FOA.

What is the intent behind restricting eligibility to foreign institutions?

The stated structure is designed to strengthen and enable high-quality infectious disease research led by institutions based in eligible foreign, resource-constrained settings, rather than funding extensions of U.S.-based applicants.

Is cost sharing or matching required?

No. There is no cost sharing or matching requirement stated for this opportunity.

What funding activity area does this opportunity fall under?

It is categorized in the health funding activity area and is described as NIH discretionary funding.

Which CFDA numbers are associated with this announcement?

The opportunity is associated with CFDA 93.855 (Allergy, Immunology and Transplantation Research) and CFDA 93.856 (Microbiology and Infectious Diseases Research).

What do the listed CFDA numbers suggest about the scientific scope?

They indicate alignment with NIAID interests in areas such as immunology, microbial pathogenesis, infectious disease biology, prevention, and related translational or clinical work.

When was the FOA posted and created?

The FOA was posted and created on March 11, 2011.

What was the application due date?

The original and final application closing date listed is August 23, 2013.

Is this funding opportunity still open for new applications?

No. The announcement was archived on September 23, 2013, and is no longer active for new submissions.

Where can someone find the full official announcement?

The archived FOA page is available at: http://grants.nih.gov/grants/guide/pa-files/PAR-11-145.html

Who should be contacted for technical issues accessing the FOA page?

NIH listed the NIH Office of Extramural Research (OER) webmaster contact for technical access or linking issues: FBOWebmaster@OD.NIH.GOV

What does "important to the applicant country" mean in the context provided?

As described, it means the research questions should be closely tied to the local public health priorities and infectious disease burdens of the country where the applicant institution is located.

Does the provided description specify an award budget or project period?

No. The information provided does not include specific award budget limits or project period details.

Does the provided description list specific eligible foreign countries?

No. It states eligibility is limited to organizations located in "eligible foreign countries" but does not list the specific countries in the provided excerpt.

Browse more business programs for Infectious Disease Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Assembling, Visualizing, and Analyzing the Tree of Life

Previous opportunity: ROSES 2011 Planetary Geology and Geophysics

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 11 145

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 11 145) also looked into and applied for these:

Funding Opportunity
Centers for Education and Research on Therapeutics (CERTs) Scientific Forum (U19) Apply for RFA HS 11 003

Funding Number: RFA HS 11 003
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Centers for Education and Research on Therapeutics (CERTs)( U19) Apply for RFA HS 11 004

Funding Number: RFA HS 11 004
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Cooperative Agreement to Support State Assessment Initiatives Apply for CDC RFA HK07 70205CONT11

Funding Number: CDC RFA HK07 70205CONT11
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
HAITI REHABILITATION AND REINTEGRATION OF PERSONS WITH DISABILITIES PROGRAM Apply for USAID HAITI RFA 521 10 033

Funding Number: USAID HAITI RFA 521 10 033
Agency: Haiti USAID Port Au Prince
Category: Health
Funding Amount: $9,000,000
NINDS Cooperative Program in Translational Research Single Component Research Projects (U01) Apply for PAR 11 153

Funding Number: PAR 11 153
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis (U01) Apply for PAR 11 154

Funding Number: PAR 11 154
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Minority Fellowship Program Apply for SM 11 005

Funding Number: SM 11 005
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $900,000
CDC Mexico Cooperative Agreement for Surveillance, Epidemiology, and Laboratory Capacity Apply for CDC RFA CK11 1106

Funding Number: CDC RFA CK11 1106
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
Engaging Indigenous Organizations to Sustain and Enhance Comprehensive HIV/AIDS Services in 26 States of the Federal Republic of Nigeria under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1112

Funding Number: CDC RFA GH11 1112
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $55,000,000
Initiatives Related to the Prevention and Control of Unintentional Injury and Violence Through the World Health Organization (WHO) Apply for CDC RFA CE11 1104

Funding Number: CDC RFA CE11 1104
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Evidence to Action for Strengthened Family Planning and Reproductive Health Services for Women and Girls (E2A) Apply for SOL OAA 11 000041

Funding Number: SOL OAA 11 000041
Agency: Agency for International Development
Category: Health
Funding Amount: $230,000,000
STRENGTHENING HUMAN RESOURCES FOR HEALTH (HRH) PROGRAM Apply for RFA 663 11 000009

Funding Number: RFA 663 11 000009
Agency: Ethiopia USAID Addis Ababa
Category: Health
Funding Amount: $55,000,000
Nutrition and Diet in the Causation, Prevention, and Management of Heart Failure (R01) Apply for PA 11 165

Funding Number: PA 11 165
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Nutrition and Diet in the Causation, Prevention, and Management of Heart Failure (R21) Apply for PA 11 166

Funding Number: PA 11 166
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Phase II Clinical Trials of Novel Therapies for Lung Diseases (UM1) Apply for RFA HL 12 022

Funding Number: RFA HL 12 022
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Improved Diagnostic Capabilities for Select Biodefense and Emerging Pathogens (R21/R33) Apply for RFA AI 11 024

Funding Number: RFA AI 11 024
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immune Deficiency (SCID) Apply for RFA EH 11 001

Funding Number: RFA EH 11 001
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $450,000
Instructions for Preparing an Interim Progress Report Apply for CDC RFA HM07 70205CONT11

Funding Number: CDC RFA HM07 70205CONT11
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Instructions for Preparing an Interim Progress Report Apply for CDC RFA HM07 70305CONT11

Funding Number: CDC RFA HM07 70305CONT11
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Improving Surveillance for Diseases of Public Health Significance for U.S. Bound Refugees and Other Mobile Populations Thailand Apply for CDC RFA CK11 1103

Funding Number: CDC RFA CK11 1103
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 145", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.